LFMD LifeMD, Inc.
Q3 2025 10-Q
Filed: Nov 17, 2025Period ending Sep 30, 2025
Health Care
Services-Offices & Clinics of Doctors of MedicineSEC EDGAR LifeMD, Inc. (LFMD) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 17, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • No new risk factors added this quarter; risks same as 2024 10-K
- • Most material risk carried forward: significant regulatory scrutiny from SEC and state health authorities
Quarterly Financial SummaryXBRL
Revenue
$59M
▲ +10.6% YoY▼ -5.1% QoQ
Net Income
-$5M
▲ +4.1% YoY▼ -137.1% QoQ
Gross Margin
87.5%
▼ -315bp YoY▼ -60bp QoQ
Operating Margin
-5.2%
▲ +356bp YoY▼ -376bp QoQ
Net Margin
-8.3%
▲ +128bp YoY▼ -499bp QoQ
ROE
-374.3%
Total Assets
$66M
Operating Cash Flow
-$147,136
▼ -102.4% YoY▼ -101.7% QoQ
Source: XBRL data from LifeMD, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on LifeMD, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.